PULMONX CORPORATION Deferred Tax Assets, Operating Loss Carryforwards
PULMONX CORPORATION (LUNG) had Deferred Tax Assets, Operating Loss Carryforwards of $76.65 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $76.65M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $65.52M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $57.42M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $50.32M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $76.65M 10-K · filed 2026-03-10 |
| 2024-12-31 | $65.52M 10-K · filed 2026-03-10 |
| 2023-12-31 | $57.42M 10-K · filed 2025-02-25 |
| 2022-12-31 | $50.32M 10-K · filed 2024-02-27 |
| 2021-12-31 | $43.80M 10-K · filed 2023-03-01 |
| 2020-12-31 | $30.40M 10-K · filed 2022-03-01 |
| 2019-12-31 | $22.50M 10-K · filed 2021-03-15 |
| 2018-12-31 | $19.52M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |